Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren’s syndrome

References

• Jonsson R, Bolstad AI, Brokstad KA, et al. Sjogren’s syndrome–a plethora of clinical and immunological phenotypes with a complex genetic background. Ann NY Acad Sci. 2007;1108(1):433–447.
   PubMedGoogle Scholar
• Jonsson R, Vogelsang P, Volchenkov R, et al. The complexity of Sjogren’s syndrome: novel aspects on pathogenesis. Immunol Lett. 2011;141(1):1–9.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, et al. Topical and systemic medications for the treatment of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2012;8(7):399–411.
   PubMed Web of Science ®Google Scholar
• Garberg H, Jonsson R, Brokstad KA. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjogren’s syndrome patients and healthy controls. Scand J Rheumatol. 2005;34(1):49–55.
   PubMed Web of Science ®Google Scholar
• Gordon TP, Bolstad AI, Rischmueller M, et al. Autoantibodies in primary Sjogren’s syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity. 2001;34(2):123–132.
   PubMed Web of Science ®Google Scholar
• Volchenkov R, Jonsson R, Appel S. Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjogren’s syndrome using luciferase immunoprecipitation systems (LIPS). Scand J Rheumatol. 2012;41(4):314–315.
   PubMed Web of Science ®Google Scholar
• Halse A, Harley JB, Kroneld U, et al. Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjogren’s syndrome. Clin Exp Immunol. 1999;115:203–207.
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Wahren-Herlenius M. Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjogren’s syndrome. Scand J Rheumatol. 2003;32(2):79–82.
   PubMed Web of Science ®Google Scholar
• Wahren-Herlenius M, Salomonsson S. Detection of antigen specific B-cells in tissues. Methods Mol Med. 2007;136:19–24.
   PubMedGoogle Scholar
• Jonsson R, Theander E, Sjostrom B, et al. Autoantibodies present before symptom onset in primary Sjogren syndrome. JAMA. 2013;310(17):1854–1855.
   PubMed Web of Science ®Google Scholar
• Theander E, Jonsson R, Sjostrom B, et al. Prediction of Sjogren’s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol. 2015;67:2427–2436.
   PubMed Web of Science ®Google Scholar
• Komai K, Shiozawa K, Tanaka Y, et al. Sjogren’s syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment. Mod Rheumatol. 2009;19(4):416–419.
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Brokstad KA, Jakobsen K, et al. Low number of memory B cells in the salivary glands of patients with primary Sjogren’s syndrome. Autoimmunity. 2012;45(7):547–555.
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Skarstein K, Oijordsbakken G, et al. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjogren’s syndrome. Clin Exp Immunol. 2013;172(2):228–237.
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Kvarnstrom M, Brokstad KA, et al. Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjogren’s syndrome. Clin Exp Immunol. 2014;177(1):244–252.
   PubMed Web of Science ®Google Scholar
• Sims GP, Lipsky PE. Isolation of human B cell populations. Curr Protoc Immunol. 2006;7(7):5.
   PubMedGoogle Scholar
• Haghighi M, Khanahmad H, Palizban A. Selection and characterization of single-stranded DNA aptamers binding human B-cell surface protein CD20 by cell-SELEX. Molecules. 2018;23(4):715.
   Web of Science ®Google Scholar
• Agematsu K, Hokibara S, Nagumo H, et al. CD27: a memory B-cell marker. Immunol Today. 2000;21(5):204–206.
   PubMedGoogle Scholar
• Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188(9):1679–1689.
   PubMed Web of Science ®Google Scholar
• Klein U, Kuppers R, Rajewsky K. Human IgM + IgD + B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol. 1993;23(12):3272–3277.
   PubMed Web of Science ®Google Scholar
• Bohnhorst JO, Bjorgan MB, Thoen JE, et al. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren’s syndrome. J Immunol. 2001;167(7):3610–3618.
   PubMed Web of Science ®Google Scholar
• Pascual V, Liu YJ, Magalski A, et al. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994;180(1):329–339.
   PubMed Web of Science ®Google Scholar
• Jung J, Choe J, Li L, et al. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur J Immunol. 2000;30(8):2437–2443.
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Skarstein K, Jonsson R, et al. Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice. Autoimmunity. 2011;44(5):415–426.
   PubMed Web of Science ®Google Scholar
• Szyszko EA, Brokstad KA, Oijordsbakken G, et al. Salivary glands of primary Sjogren’s syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther. 2011;13(1):R2.
   PubMed Web of Science ®Google Scholar
• Hansen A, Lipsky PE, Dorner T. B cells in Sjogren’s syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther. 2007;9(4):218.
   PubMed Web of Science ®Google Scholar
• Jonsson R, Nginamau E, Szyszko E, et al. Role of B cells in Sjogren’s syndrome–from benign lymphoproliferation to overt malignancy. Front Biosci. 2007;12(1):2159–2170.
   PubMedGoogle Scholar
• Gatumu MK, Skarstein K, Papandile A, et al. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren’s syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther. 2009;11(1):R24.
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Skarstein K, Jonsson R, et al. Serological implications of germinal center-like structures in primary Sjogren’s syndrome. J Rheumatol. 2007;34:2044–2049.
   PubMed Web of Science ®Google Scholar
• Hamel KM, Liarski VM, Clark MR. Germinal center B-cells. Autoimmunity. 2012;45(5):333.
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren’s syndrome. Arthritis Rheum. 2003;48(11):3187–3201.
   PubMed Web of Science ®Google Scholar
• Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren’s syndrome. Ann Rheum Dis. 2011;70(8):1363–1368.
   PubMed Web of Science ®Google Scholar
• Cornec D, Devauchelle-Pensec V, Tobon GJ, et al. B cells in Sjogren’s syndrome: From pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39(3):161–167.
   PubMed Web of Science ®Google Scholar
• Isaksen K, Jonsson R, Omdal R. Anti-CD20 treatment in primary Sjogren’s syndrome. Scand J Immunol. 2008;68(6):554–564.
   PubMed Web of Science ®Google Scholar
• Cornec D, Devauchelle-Pensec V, Tobon GJ, et al. B cells in Sjogren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39(3):161–167.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Li L, Boumba D, et al. Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren’s syndrome. Clin Exp Rheumatol. 1998;16(1):63–65.
   PubMed Web of Science ®Google Scholar
• Skarstein K, Aqrawi LA, Oijordsbakken G, et al. Adipose tissue is prominent in salivary glands of Sjogren’s syndrome patients and appears to influence the microenvironment in these organs. Autoimmunity. 2016;49(5):338–346.
   PubMed Web of Science ®Google Scholar
• Aqrawi LA, Jensen JL, Oijordsbakken G, et al. Signalling pathways identified in salivary glands from primary Sjogren’s syndrome patients reveal enhanced adipose tissue development. Autoimmunity. 2018;51(3):135–146.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558.
   PubMed Web of Science ®Google Scholar
• Fonseca JE, Santos MJ, Canhao H, et al. Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev. 2009;8(7):538–542.
   PubMed Web of Science ®Google Scholar
• Zhou J, Jin JO, Patel ES, et al. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions. Cytokine. 2015;76(2):244–252.
   PubMed Web of Science ®Google Scholar
• Jin JO, Han X, Yu Q. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun. 2013;40:28–44.
   PubMed Web of Science ®Google Scholar
• Reksten TR, Jonsson MV, Szyszko EA, et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren’s syndrome. Rheumatology (Oxford). 2009;48(9):1102–1106.
   PubMed Web of Science ®Google Scholar
• Leehan KM, Pezant NP, Rasmussen A, et al. Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjogren’s syndrome. Autoimmunity. 2017;50(8):451–457.
   PubMed Web of Science ®Google Scholar
• Asam S, Neag G, Berardicurti O, et al. The role of stroma and epithelial cells in primary Sjogren’s syndrome. Rheumatology (Oxford). 2019.
   PubMedGoogle Scholar